-
Markets
-
Equities
Sustainable finance2025 Euronext ESG Trends ReportRead moreA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesRead moreThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETFs
The European market place for ETFsEuronext ETF EuropeRead moreInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Funds
-
Fixed Income
European Defence BondsGroupe BPCE lists the first bondRead moreFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Structured Products
-
Derivatives
Where European Government Bonds Meet the FutureFixed Income derivativesRead moreTrade mini bond futures on main European government bonds
-
Commodities
- Overview
- Quotes snapshot
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Delivery & settlement
- Specifications & arrangements
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesRead moreEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Resources
Designed to help students navigate the complexities of financial marketsEuronext Trading gameRead moreJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
Observe Medical with progress in Italy: Major tender win, exclusive distribution agreement and significant order
25 Sep 2025 16:05 CEST
Issuer
Observe Medical ASA
Oslo, 25 September 2025 - Observe Medical ASA (the "Company" or "Observe
Medical") announces further progress in the Italian market.
The Company's distributor in Italy has secured a public tender to supply
UnoMeterT products into the largest region in Italy, corresponding to an
estimated olume of approximately 240,000 units annually for a period of three
years.
Following extended cooperation, Observe Medical has also entered into a mutually
exclusive distribution agreement with the distributor for the UnoMeterT product
family in Italy. In addition, the Company has received a significant order
related to this agreement.
Jørgen Mann, CEO of Observe Medical, commented: "Italy has historically been one
of the markets where the UnoMeterT products have held the highest market shares
and by winning the largest region in Italy which represents more than 15% of the
market, on top of the already gained business, secures a strong growth for
Observe Medical and a solid basis for further market share expansion".
Observe Medical reminds investors, analysts, and other stakeholders of the
Company's upcoming trading update on Tuesday 7 October 2025, at 09:00 CET, which
will be held virtually and streamed via webcast at the following
link: https://channel.royalcast.com/landingpage/hegnarmedia/20251007_1/ (https:
/
/eur03.safelinks.protection.outlook.com/?url=https%3A%2F%2Fchannel.royalcast.com
%
2Flandingpage%2Fhegnarmedia%2F20251007_1%2F&data=05%7C02%7Cjohan.fagerli%40obser
v
emedical.com%7Ce9b067cb4eae445bddd108ddf67e93ae%7C139dbc03ecf246efb467a338c990a8
d
6%7C0%7C0%7C638937745682186722%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsI
l
YiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&
s
data=v%2BxiEF3WLlkQUQ8LiZLpGaqwOEgGImgwVwBOYtfEaDg%3D&reserved=0)
For further information, please contact:
Jørgen Mann, CEO Observe Medical
Mobile: +45 408 67558
E-mail: jorgen.mann@observemedical.com
Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12765
E-mail: johan.fagerli@observemedical.com
About Observe Medical
Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.
The Company seeks to drive growth by leveraging its expertise in sales and
commercialization of its broad portfolio of medical technology products, mainly
in urine measurement and ultrasound, in combination with targeted M&A and
distribution. Observe Medical is working with a network of leading distributors
to provide outstanding solutions for healthcare professionals globally.
The Company is headquartered in Oslo, Norway.
Further information is available atwww.observemedical.com.
More information:
Access the news on Oslo Bors NewsWeb site
Source
Observe Medical ASA
Provider
Oslo Børs Newspoint
Company Name
OBSERVE MEDICAL
ISIN
NO0013457952
Symbol
OBSRV
Market
Euronext Expand